Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness

Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness

IntroductionGeneralized Anxiety Disorder (GAD) is a mental health condition with a recent increase in prevalence. GAD is often underdiagnosed, leading to negative consequences for individuals, healthcare systems, and society. The economic burden and impaired quality of life associated with GAD under...

Full description

Saved in:
Bibliographic Details
Main Authors: Narcis Cardoner, Luis Gutiérrez-Rojas, Pilar Saiz, Guillermo Lahera, Miguel Ángel Álvarez-Mon, Pino Alonso Ortega, María Pérez-Páramo
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Pharmacology
Subjects:
pregabalin
benzodiazepines
SSRIs
SNRIs generalized anxiety disorder
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1483770/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items